Hematopoietic JAK2V617F Mutation-Induced Reprograming of Blood and Bone Marrow Megakaryocytes

Authors

Institutions

Publication Details

Journal
Blood Advances
Published
2026-02-18
DOI
https://doi.org/10.1182/bloodadvances.2025019504
Primary Topic
Myeloproliferative Neoplasms: Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Hematopoietic JAK2V617F Mutation-Induced Reprograming of Blood and Bone Marrow Megakaryocytes

Katya Ravid, Nasi Huang, George J. Murphy, Anastasia Iris Karkempetzaki et al.
Blood Advances
Myeloproliferative Neoplasms: Diagnosis and Treatment
article

Hematopoietic JAK2V617F Mutation-Induced Reprograming of Blood and Bone Marrow Megakaryocytes

Katya Ravid, Nasi Huang, George J. Murphy, Anastasia Iris Karkempetzaki, Simon Liang Lu, Chao Zhang
article en

Abstract

No abstract available for this paper.
Blood Advances
Boston University (US), Boston Medical Center (US)
National Heart, Lung, and Blood Institute
Zero hunger
Openalex Percentile: Top 52%
Myeloproliferative Neoplasms: Diagnosis and Treatment
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.